Effects of ethinylestradiol-cyproterone acetate vs. pioglitazone-flutamide-metformin on plasma FGF21 levels in adolescent girls with androgen excess.

M Díaz, J M Gallego-Escuredo, F de Zegher, F Villarroya, L Ibáñez

Journal: Diabetes & metabolism 2017;42(3):196-9

PMID: 26546387

Full Text on Elsevier Science View on PubMed

Abstract

Address: Endocrinology, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), ISCIII, Madrid, Spain.; Department of Biochemistry and Molecular Biology, and Institute of Biomedicine, University of Barcelona, 08028 Barcelona, Spain; Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición (CIBEROBN), ISCIII, Madrid, Spain.; Department of Development and Regeneration, University of Leuven, Leuven, Belgium.; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), ISCIII, Madrid, Spain. Electronic address: [email protected].

DOI: 10.1016/j.diabet.2015.10.004

Link outs

Free resources

Other Literature Sources:

https://scite.ai/reports/26546387

Subscription / membership required

Full Text Sources:

MeSH Terms: Adolescent, Cyproterone Acetate, Drug Combinations, Ethinyl Estradiol, Female, Fibroblast Growth Factors, Flutamide, Hirsutism, Humans, Hyperandrogenism, Hyperinsulinism, Longitudinal Studies, Metformin, Pioglitazone, Thiazolidinediones